Advanced Enzyme Technologies Q4 Results
- BSE: 540025
- NSE: ADVENZYMES
- ISIN: INE837H01020
- Sector: Biotechnology & Drugs
BSE
321.60
-3.30 (-1.02%)
-3.30 (-1.02%)Volume8.30 K
Updated: Fri 17 Jul, 2026 | 15:29:44
NSE
320.60-4.45 (-1.37%)
-4.45 (-1.37%)Volume2.39 L
Updated: Fri 17 Jul, 2026 | 15:31:14
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹203.37 Cr.(21.65%)
- Operating Profit₹53.15 Cr.(49.61%)
- Profit After Tax₹42.96 Cr.(62.24%)
- Operating Margin26.13%(22.98%)
Note: Comparison is on YoY basis
Quarterly - Advanced Enzyme Technologies Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 150.22 | 121.56 | 23.58% | 126.85 | 14.10% |
| Depreciation/ Amortization | 10.19 | 10.21 | -0.14% | 9.28 | 1.16% |
| Operating Income | 53.15 | 50.39 | 5.48% | 30.96 | 49.61% |
| Net Income | 42.96 | 42.50 | 1.09% | 28.31 | 62.24% |
| Other Operating Expenses Total | 41.27 | 39.93 | 3.36% | 34.45 | 6.77% |
| Net Income Before Taxes | 59.80 | 58.29 | 2.60% | 39.61 | 37.61% |
| Total Revenue | 203.37 | 171.95 | 18.27% | 157.82 | 21.65% |
| Selling/ General/ Admin Expenses Total | 41.94 | 41.26 | 1.64% | 32.48 | 13.85% |
| Diluted Normalized EPS | 3.83 | 3.05 | 25.68% | 3.54 | 61.79% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.